Cargando…
Circulating Mature PCSK9 Level Predicts Diminished Response to Statin Therapy
BACKGROUND: Statin‐mediated efficacy of lowering low‐density lipoprotein (LDL) cholesterol varies in each individual, and its diminished response is associated with worse outcomes. However, there is no established approach to predict hyporesponse to statins. PCSK9 (proprotein convertase subxilisin/k...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483520/ https://www.ncbi.nlm.nih.gov/pubmed/33998287 http://dx.doi.org/10.1161/JAHA.120.019525 |